Jianmei Huang

Dr. Jianmei Huang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2022 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
JHJianmei Huang
Jianmei Huang
MLMeiying Li
Meiying Li
BMBingjie Mei
Bingjie Mei
JLJunyang Li
Junyang Li
YZYi Zhu
Yi Zhu
GZGuonan Zhang
Guonan Zhang
Background: Aberrant sialoglycans on the surface of tumor cells shield potential tumor antigen epitopes, escape recognition, and suppress activation of immunocytes. α2,3/α2,6Gal- and α2,6GalNAc (Gal/GalNAc)-linked sialic acid residues of sialoglycans could affect macrophage galactose-type lectins (MGL) mediated-antigen uptake and presentation and promote sialic acid-binding immunoglobulin-like lectins (Siglecs) mediated-immunosuppression. Desialylating sialoglycans on tumor cells could present tumor antigens with Gal/GalNAc residues and overcome glyco-immune checkpoints. Thus, we explored whether vaccination with desialylated whole-cell tumor vaccines (DWCTVs) triggers anti-tumor immunity in ovarian cancer (OC). Methods: Sialic acid (Sia) and Gal/GalNAc residues on OC A2780, OVCAR3, and ID8 cells treated with α2-3 neuraminidase (α2-3NA) and α2-6NA, and Sigec-9 or Siglec-E and MGL on DCs pulsed with desialylated OC cells were identified using flow cytometry (FCM); RT-qPCR determined IFNG expression of T cells, TRBV was sequenced using Sanger sequencing and cytotoxicity of αβ T cells was measured with LDH assay; Anti-tumor immunity in vivo was validated via vaccination with desialylated whole-cell ID8 vaccine (ID8 DWCTVs). Results: Gal/GalNAc but not Sia residues were significantly increased in the desialylated OC cells. α2-3NA-modified DWCTV increased MGL but decreased Siglec-9 or Siglec E expression on DCs. MGLbright/Siglec-9dim DCs significantly up-regulated IFNG expression and CD4/CD8 ratio of T cells and diversified the TCR repertoire of αβ T-cells that showed enhanced cytotoxic activity. Vaccination with α2-3NA-modified ID8 DWCTVs increased MGLbright/Siglec-Edim DCs in draining lymph nodes, limited tumor growth, and extended survival in tumor-challenged mice. Conclusion: Desialylated tumor cell vaccine could promote anti-tumor immunity and provide a strategy for OC immunotherapy in a clinical setting.

30 January 2026 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
YLYibing Lv
Yibing Lv
CWChunyu Wu
Chunyu Wu
JXJunyi Xiao
Junyi Xiao
WYWenke Yang
Wenke Yang
CWChenyang Wang
Chenyang Wang
SLShixiu Liao
Shixiu Liao
Background: IREB2 is an RNA-binding protein that modulates cellular iron uptake and storage by regulating ferritin expression. Mutations in the IREB2 gene have been shown to induce degradation of the IREB2 protein, resulting in the upregulation of FTH1 protein expression, which contributes to iron storage. This study investigates the potential mechanism of the Ireb2 D826V/D826V mutation on lipid biosynthesis for the first time. Results: In this study, it was discovered for the first time that Ireb2 D826V/D826V mice exhibited increased body weight, hypertrophic adipocytes, iron and lipid accumulation. RNA-sequencing analysis suggests that the Ireb2 D826V/D826V mutation potentially activates pathways involved in fatty acid and triglyceride biosynthesis. This activation is evidenced by the upregulation of lipid biosynthetic genes, including Fasn , Acaca , Acly , Fgfr4 , and Egr1 , along with their corresponding protein expressions in Ireb2 D826V/D826V mice. These molecular changes occur alongside the degradation of IREB2, an increase in FTH1 expression and iron accumulation in tissues. Metabolomic analysis confirmed that the Ireb2 D826V/D826V mutation indeed elevated the levels of certain fatty acids and triglyceride components in epWAT. Moreover, in vitro experiments utilizing adipocytes confirmed that the Ireb2 D826V/D826V mutation augmented fatty acid and triglyceride biosynthesis, as well as the expression of associated proteins, contingent upon iron accumulation. Conclusion: The Ireb2 D826V/D826V mutation is linked to the degradation of IREB2, increased expression of FTH1, and iron accumulation. These molecular alterations are associated with elevated protein levels of ACACA, ACLY, FASN, EGR1, and FGFR4, which correlate with enhanced lipid biosynthesis and subsequent weight gain. This study elucidates a link between dysregulated iron storage, mediated via the IREB2-FTH1 axis, and the upregulation of key lipogenic genes, resulting in enhanced lipid biosynthesis. These findings underscore a potential relationship between iron metabolism and obesity, suggesting that iron homeostasis could serve as a valuable target for further mechanistic investigation and therapeutic development in the context of obesity.

15 October 2026 in Human Genomics
Verified
Journal Article
Open access
PDF file
JHJianmei Huang
Jianmei Huang
ZGZhenglong Guo
Zhenglong Guo
WYWenke Yang
Wenke Yang
WSWeili Shi
Weili Shi
ZWZhaokun Wang
Zhaokun Wang
SLShixiu Liao
Shixiu Liao
Following the initial report linking immunoglobulin-binding protein 1 (IGBP1, OMIM 300139) mutations to X-linked intellectual disability (XLID), we identif